Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
about
Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseasesNeuropathology of non-Alzheimer degenerative disordersMolecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision MedicineArgyrophilic grain diseaseThe role of α-synuclein and tau hyperphosphorylation-mediated autophagy and apoptosis in lead-induced learning and memory injuryInteractions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.Multiprotein deposits in neurodegenerative disorders: our experience in the tissue brain bank of Navarra.Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Lewy bodies.A powerful yeast model to investigate the synergistic interaction of α-synuclein and tau in neurodegeneration.Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly.An individualized approach to treatment for alzheimer's disease, pick's disease, and other dementias.Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.Genetic aspects of Alzheimer diseaseThe Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases.Neuropathology underlying clinical variability in patients with synucleinopathies.Inflammation in the early stages of neurodegenerative pathologyFractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases.Invited review: Neuropathology of tauopathies: principles and practice.Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models.Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy.The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.A Focus on the Beneficial Effects of Alpha Synuclein and a Re-appraisal of Synucleinopathies.Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.Pick's pathology in Parkinson's disease with dementia.Alpha-synuclein alters proteasome function, protein synthesis, and stationary phase viability.Neuritic Pathology as a Correlate of Synaptic Loss in Dementia With Lewy Bodies
P2860
Q24633202-0A3DCE46-43F5-4DE1-B549-36457554C824Q24657571-A57D9649-C28F-4AA2-8F59-92689B180745Q26768648-1FDB8E0F-D2D2-4818-BD97-25C1716C34D8Q28266563-F7EEBBE8-C26F-4269-8385-4571B5D4E8D3Q28386471-EDDB5D83-DD17-4102-9E43-61754A6EE3B5Q30577687-0E0070D1-2634-41D3-9A18-97FDB8218711Q33453702-DC1C574F-523F-4E26-9AC0-E1D537997836Q33552220-6ABD1A9E-3C51-4AF6-AC09-D792F276BF51Q34193337-710ADE33-A425-4876-B296-102BA67EE9C2Q34478663-0E952C10-C24F-4FDD-87E0-4E6C6914A72CQ34581042-A28BE82E-A663-4389-B98E-79F3349B05B4Q35024248-560299BA-66B4-4BF1-AE50-2D84C584D792Q35380017-01CB9522-0ACB-45E0-984A-9A9108228954Q36633738-57A2C7F3-BC4D-4D04-A9B2-A71769C6E91CQ37038032-1DB59AF1-3BA5-404E-9ECA-AE73BBCB013CQ37127867-8F7A1FE2-B973-4112-A650-DA0C999079E7Q37139063-1207A962-3585-460F-9D36-41FC55E2EFD1Q37855544-9B82E397-3B51-4963-B0E1-AE484D2D9077Q37896515-84C602D9-166A-46BB-B23F-ED739381FA41Q37912590-8981D7D7-F8DB-4C73-9D9E-36BDE3463DFDQ38037524-79DA4259-D51E-4E4B-9A2F-F76A339B3DCBQ38286208-144BC5EB-8B98-4C0F-8C41-825262047590Q38311234-DC20B47F-9D0C-4AB9-943C-F273D5E2BA89Q38404368-D7176952-3C8B-4EF7-9F48-E58B40D4122CQ38915426-CA71FA0F-F16C-4806-BD3C-2001D1925ACCQ39994322-835ACB23-6FA3-45AB-9835-DE1199E822D8Q41985945-10980AD3-76E3-4809-8DC9-D14B370851A2Q46251905-79A76D40-8FF2-4572-8AA5-46C3CF9B10CEQ47389795-36614D1B-6D46-4FCB-9AD9-4EF6302AB5A7Q48263978-37E32CD1-98D6-46C4-983F-6D0BFB07908CQ48477277-CD216893-8A9A-4DE3-A963-C24B8620AC91Q54660240-D5915ACC-88C8-49F6-86C1-B6BEE68089C7Q57194176-FA51EF35-4065-446D-9398-03A701784CF8
P2860
Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Lewy bodies in the amygdala: i ...... ses with tau-based inclusions.
@ast
Lewy bodies in the amygdala: i ...... ses with tau-based inclusions.
@en
type
label
Lewy bodies in the amygdala: i ...... ses with tau-based inclusions.
@ast
Lewy bodies in the amygdala: i ...... ses with tau-based inclusions.
@en
prefLabel
Lewy bodies in the amygdala: i ...... ses with tau-based inclusions.
@ast
Lewy bodies in the amygdala: i ...... ses with tau-based inclusions.
@en
P2093
P1433
P1476
Lewy bodies in the amygdala: i ...... ses with tau-based inclusions.
@en
P2093
Anca Popescu
Carol F Lippa
Virginia M-Y Lee
P304
P356
10.1001/ARCHNEUR.61.12.1915
P577
2004-12-01T00:00:00Z